SAADH, M. J. SARS-COV-2 3CL-PROTEASE INHIBITORS AS ANTIVIRAL AGENT AGAINST COVID-19. International Journal of Applied Pharmaceutics, [S. l.], v. 14, n. 6, p. 18–20, 2022. DOI: 10.22159/ijap.2022v14i6.46015. Disponível em: https://journals.innovareacademics.in/index.php/ijap/article/view/46015. Acesso em: 22 nov. 2024.